BOCA RATON, FL -- (Marketwired) -- 06/11/13 -- At Stem Cell Orthopedics, Medical Director Dr. Joseph Purita and his staff, are focused on utilizing the latest practices in regenerative medicine to offer innovative procedures to patients suffering from a wide range of injuries and degenerative conditions. Specifically, Dr. Purita and the other board-certified orthopedic surgeons at Stem Cell Orthopedics concentrate on the progressive use of platelet rich plasma (PRP) injection and stem cell therapies. Although Purita has already gained increasing recognition for his revolutionary use of regenerative medicine, he is encouraged by the continuing progress found within the medical community.
As such, Dr. Joseph Purita highlights a recent study emerging from scientific researchers at the University of Pennsylvania focused in a new report from Science Daily. The article explains, "Bioengineers are interested in finding innovative ways to grow new cartilage from a patient's own stem cells, and, thanks to a new study from the University of Pennsylvania, such a treatment is a step closer to reality." Directed under the guidance of associated professor Jason Burdick, the research took a closer examination of how stem cells may improve and resolve the natural deterioration of cartilage experienced through aging, or sports injuries.
In the article, Burdick explains, "The broad picture is trying to develop new therapies to replace cartilage tissue, starting with focal defects -- things like sports injuries -- and then hopefully moving toward surface replacement for cartilage degradation that comes with aging. Here, we're trying to figure out the right environment for adult stem cells to produce the best cartilage."
Dr. Joseph Purita responds to the study, "Having successfully treated notable athletes with regenerative medicine procedures -- such as PRP therapy -- I am confident that stem cells will continue to offer more comprehensive benefits over traditional resolutions. While the research continues to develop, it is encouraging that in the near future patients will no longer have to opt for expensive invasive surgery options to repair damaged cartilage, joints, tissue, blood vessels and bone."
While Dr. Joseph Purita is excited by the scientific developments offered by the University of Pennsylvania research, he explains that there are many other benefits that may come with further studies. "While the scientific understanding of stem cells is critical to applying the resource in regenerative medicine, it is important to note that continued research will help ease the public's perception of regenerative medicine. As patients come to understand that the solution can be found in our own bodies, I believe the public will prove more open to these types of innovative therapies," Dr. Joseph Purita concludes.
Dr. Joseph Purita is the Medical Director Stem Cell Orthopedics, a medical facility based in Boca Raton, Florida that specializes in regenerative medicine treatments. The facility serves a wide range of patients who are experiencing chronic pain as the result of a degenerative disorder or physical injury. This center is equipped with experienced board-certified orthopedic surgeons who understand how to target and treat specific conditions ranging from rheumatoid arthritis to tears in muscle tissue. While founded on a conventional knowledge of traditional orthopedics, this facility is regarded for its progressive use of emerging methodologies, including platelet rich plasma (PRP) injection, stem cell and cytokine therapies.
Most Popular Stories
- NSA Defends Global Cellphone Tracking Legality
- Top Websites for U.S. Hispanics
- Ad Counts Rise in 2013 for Hispanic Magazines
- Networks Vie for U.S. Hispanic TV Viewers
- Saab Gets Back into the Game; U.S. Auto Sales Soar
- Apple Activates Customer-Tracking iBeacon
- Dell Offers Undisclosed Number of Employee Buyouts
- 2013 Tech Gift Guide: iPad Mini Still Hot; Chromecast a Great Low-Cost Option
- A Biography of Jonathan Ive, Apple's Creative Chief
- Authorities Close to Deal with JPMorgan Chase over Madoff Response